Lantz Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.4M Buy
2,003
+18
+0.9% +$18.4K 0.44% 61
2026
Q1
$1.83M Buy
1,985
+3
+0.2% +$3.04K 0.38% 73
2025
Q4
$2.13M Buy
1,982
+103
+5% +$98.5K 0.45% 58
2025
Q3
$1.43M Buy
1,879
+53
+3% +$39.4K 0.32% 87
2025
Q2
$1.42M Sell
1,826
-60
-3% -$46.6K 0.35% 82
2025
Q1
$1.56M Buy
1,886
+175
+10% +$146K 0.43% 72
2024
Q4
$1.32M Buy
1,711
+107
+7% +$88.6K 0.35% 77
2024
Q3
$1.42M Buy
1,604
+368
+30% +$331K 0.38% 77
2024
Q2
$1.12M Buy
1,236
+16
+1% +$12.8K 0.35% 80
2024
Q1
$949K Buy
1,220
+19
+2% +$13.5K 0.31% 84
2023
Q4
$700K Sell
1,201
-18
-1% -$10.5K 0.25% 92
2023
Q3
$655K Buy
1,219
+109
+10% +$56.2K 0.26% 91
2023
Q2
$521K Buy
1,110
+94
+9% +$39.4K 0.2% 106
2023
Q1
$349K Hold
1,016
0.15% 127
2022
Q4
$372K Hold
1,016
0.17% 125
2022
Q3
$329K Hold
1,016
0.17% 120
2022
Q2
$329K Hold
1,016
0.15% 123
2022
Q1
$291K Hold
1,016
0.12% 140
2021
Q4
$281K Hold
1,016
0.13% 131
2021
Q3
$235K Hold
1,016
0.12% 133
2021
Q2
$233K Buy
+1,016
New +$204K 0.12% 135
2021
Q1
Sell
-1,249
Closed -$211K 135
2020
Q4
$211K Buy
+1,249
New +$186K 0.13% 117
2020
Q3
Sell
-1,286
Closed -$211K 122
2020
Q2
$211K Buy
+1,286
New +$197K 0.15% 105

Other funds holding LLY

Lantz Financial's LLY Position: Q2 2026 in Review

Lantz Financial increased its Eli Lilly (LLY) stake by 0.91% in Q2 2026, buying an estimated $18.4K and bringing the position to 2,003 shares worth $2.4M. The position accounts for 0.44% of the portfolio, ranked #61.

Lantz Financial first reported a position in LLY in Q2 2020 and has held it in 23 quarters since. 1,103 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lantz Financial held 2,003 shares of Eli Lilly worth $2.4M as of Q2 2026.
  • Lantz Financial bought 18 Eli Lilly shares in Q2 2026, an estimated $18.4K.
  • Eli Lilly made up 0.44% of Lantz Financial's portfolio in Q2 2026, its #61 holding.
  • Lantz Financial first reported a position in Eli Lilly in Q2 2020 and has held it in 23 quarters since.
  • 1,103 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lantz Financial's 13F filing for Q2 2026, filed 9 Jul 2026.